3.2.5 - Dialogue with ethics: genetic engineering
Therapeutic genetic engineering may fulfil pikuach nefesh by preventing disease, yet enhancement, unequal access and changes crossing species boundaries raise concerns about dignity, risk and kilayim. Jewish source reasoning meets duty, consequence and character-based ethics at each boundary. The decisive question is when intervention counts as responsible healing and when human control over life becomes morally excessive.
Genetic Intervention, Healing and Responsibility
This is a dialogue lesson. The task is not to describe genetic engineering as a science topic and then add a sentence about Judaism. The task is to keep the two sides in conversation:
| Judaism side | Ethical studies side |
|---|---|
| Torah, halakhah, mitzvot, pikuach nefesh, permission to heal, human dignity, stewardship, kilayim and internal Jewish diversity. | Ethical questions about treatment, enhancement, consent, future persons, suffering, risk, justice, animal and plant use, and whether technology should be limited. |
Genetic engineering
Genetic engineering is the deliberate alteration of genetic material, for example by inserting, removing or changing genes in a human, animal, plant or microorganism.
Three distinctions stop the response becoming vague.
| Distinction | Meaning | Why it matters for Jewish responses |
|---|---|---|
| Therapy or enhancement | Therapy aims to prevent or treat disease; enhancement aims to produce preferred traits beyond medical need. | Therapy can be linked to healing and pikuach nefesh; enhancement raises sharper worries about pride, inequality, eugenics and commodifying children. |
| Somatic or germline | Somatic editing affects body cells in one treated person; germline editing may affect descendants. | Somatic therapy is easier to treat as medicine; germline editing raises consent, risk and future-generation questions. |
| Human, animal or plant use | Genetic engineering may be used in medicine, reproduction, food production, animals or crops. | Human dignity is central in human cases; kilayim, stewardship, animal welfare and environmental risk become more prominent in plant and animal cases. |
The AQA wording says "Jewish responses" because there is no single automatic Jewish answer. A careful judgement asks what kind of genetic engineering is being proposed, why it is being done, what harms are likely, and which Jewish sources and ethical principles should carry most weight.
The issue is not "Judaism versus science"; it is whether genetic power is being used for healing, responsibility and justice, or for control, risk, vanity and harm.
Jewish Sources for Healing and Limits
Jewish responses to genetic engineering are usually argued from older sources applied to a new technology. That matters for AO1: the Torah and Talmud do not mention gene editing, but Jewish ethics has source-based principles for judging medicine, creation, life and boundaries.
| Source or principle | AO1 explanation | Genetic engineering application |
|---|---|---|
| B'tzelem Elohim | Genesis 1:27 presents human beings as created in the divine image. | Genetic engineering must not imply that people are valuable only if they have desirable genes. Edited, disabled and unedited people retain dignity. |
| Human responsibility within creation | Genesis 1:28 gives humans a role of rule or mastery; Genesis 2:15 presents the human as placed in the garden to work and guard it. | Scientific power can be a responsible use of human ability, but not unlimited domination over bodies, animals or ecosystems. |
| Permission to heal | Bava Kamma 85a interprets Exodus 21:19 as granting physicians permission to heal; medical treatment is not treated as rebellion against God. | Therapeutic gene intervention can be seen as an extension of medicine when it genuinely heals and is proportionate. |
| Pikuach nefesh | Mishnah Yoma 8:6 and Yoma 85b support the principle that danger to life can override ordinary restrictions. | Preventing severe disease can carry strong Jewish moral weight, especially where life is endangered. |
| Kilayim | Leviticus 19:19 forbids certain mixtures of animals, seeds and fabrics. | Some Jews may see species-boundary concerns in genetic modification, especially in plants and animals; modern halakhic analysis must decide whether laboratory DNA methods count as the same kind of prohibited mixing. |
| Halakhah and responsa | Jewish law develops through interpretation, precedent, rabbinic reasoning and application to new cases. | Genetic engineering is judged case by case, not by a slogan such as "playing God" or "science is always good." |
These sources pull in more than one direction. Healing and preserving life can support genetic engineering. Human dignity, humility before the Creator, concern for future harm and species-boundary laws can set limits. That tension is the lesson's main AO2 material.
The source picture is balanced: Jewish ethics gives real reasons to use genetic technology for healing, and real reasons to restrict uses that damage dignity, safety, justice or the order of creation.
Therapeutic Permission
The strongest Jewish support for genetic engineering comes when the intervention is genuinely therapeutic. If a safe somatic gene therapy treats a serious inherited disease in an existing patient, it can be understood as medicine: a way to heal, preserve life and reduce suffering.
Michael J. Broyde argues from a halakhic perspective that Jewish law can be comfortable with humans as caretakers of nature, even when that means correcting natural genetic flaws. Within his account of human personhood, he treats beneficial genetic intervention as a form of medicine. This supports considering therapeutic cases through the Jewish permission to heal; it does not make every proposed intervention safe or obligatory.
The Reform responsum of the Central Conference of American Rabbis makes a similar distinction in different language. It does not find a clear Jewish prohibition against legitimate medical genetic modification and links medical use with pikuach nefesh. It is much more cautious about non-medical enhancement.
Therapeutic permission is still conditional.
| Condition | Why it matters |
|---|---|
| Serious medical purpose | Pikuach nefesh and healing carry most force when disease, disability-related suffering or danger to life is genuinely at stake. |
| Proportionate risk | A treatment that creates greater danger than the disease cannot simply be justified by good intentions. |
| Consent and dignity | The patient must not be treated merely as research material or a genetic project. |
| Privacy | Genetic information can affect relatives and communities, so disclosure needs a careful need-to-know approach. |
| Justice | If only wealthy groups can access treatment, Jewish concern for justice and communal responsibility raises an AO2 challenge. |
The dialogue with ethical studies is clear. A Benthamite may support therapy because it reduces suffering. A Kantian may support it when the patient is treated as an end and gives valid consent. Virtue ethics may support it as compassionate and practically wise. A Jewish response can agree with these ethical insights while grounding the permission in healing, pikuach nefesh, dignity and halakhic responsibility.
Therapeutic genetic engineering is often the easiest Jewish case to defend: it can be responsible medicine, not rebellion against God, if safety, consent, dignity and justice are protected.
Enhancement And Risk
Jewish support becomes weaker as genetic engineering moves from healing to enhancement. Editing genes for appearance, status, athletic ability, intelligence or parental preference is harder to connect with pikuach nefesh. It can look less like medicine and more like control over future persons.
The strongest Jewish objections are not vague fear of science. They are focused ethical concerns:
| Concern | Jewish ethical force |
|---|---|
| Human dignity | If children are selected or edited for preferred traits, people may be valued by genetic quality rather than as bearers of the divine image. |
| Eugenics | Jewish memory and moral seriousness make any attempt to rank lives by genetic desirability especially troubling. |
| Future consent | Germline editing may affect descendants who cannot consent to the inherited risk. |
| Unknown harm | A change that looks beneficial now may create medical or social harm later. |
| Inequality | Enhancement markets could intensify class divisions if wealthy parents can buy advantages. |
| Moral character | Enhancement may encourage pride, impatience, vanity or refusal to accept ordinary human limits. |
The CCAR responsum is useful here because it does not simply ban all genetic modification. It permits a more positive attitude to medical use, but warns that routine enhancement may weaken mercy, compassion, social justice and humility. That is a strong AO2 distinction: Judaism can be pro-healing without being pro-designer-babies.
"Playing God" needs care. As an objection, it is weak if it means that any human intervention in nature is wrong, because Jewish tradition permits medicine and gives humans responsibility within creation. It is stronger if it means using power without humility, wisdom, justice or respect for the person created in God's image.
Continue this lesson.
You’re previewing NovaLearn without an account. Create a free account to read the rest.
Create free account